These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28585279)

  • 41. The profile of bile acids and their sulfate metabolites in human urine and serum.
    Bathena SP; Mukherjee S; Olivera M; Alnouti Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():53-62. PubMed ID: 24212143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A targeted analysis reveals relevant shifts in the methylation and transcription of genes responsible for bile acid homeostasis and drug metabolism in non-alcoholic fatty liver disease.
    Schiöth HB; Boström A; Murphy SK; Erhart W; Hampe J; Moylan C; Mwinyi J
    BMC Genomics; 2016 Jun; 17():462. PubMed ID: 27301979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating fatty acids and risk of severe non-alcoholic fatty liver disease in the UK biobank: a prospective cohort of 116 223 individuals.
    Zhuang P; Ao Y; Liu X; Ye H; Li H; Wan X; Zhang Y; Jiao J
    Food Funct; 2024 Oct; 15(20):10527-10538. PubMed ID: 39370886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis.
    Vakhrushev YM; Lukashevich АР; Penkina IA; Suchkova EV
    Ter Arkh; 2019 Mar; 91(2):48-51. PubMed ID: 31094171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.
    Lai J; Luo L; Zhou T; Feng X; Ye J; Zhong B
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759756
    [No Abstract]   [Full Text] [Related]  

  • 46. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Quantitative assessment of intrahepatic fat content in children and adolescents with non-alcoholic fatty liver disease].
    Zhang HX; Fu JF; Huang K; Lai C; Liang L; Jiang KW
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):598-603. PubMed ID: 22898281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects.
    Einarsson C; Hillebrant CG; Axelson M
    Hepatology; 2001 May; 33(5):1189-93. PubMed ID: 11343248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Follicle-stimulating hormone is associated with non-alcoholic fatty liver disease in Chinese women over 55 years old.
    Wang N; Li Q; Han B; Chen Y; Zhu C; Chen Y; Xia F; Lu M; Meng Y; Guo Y; Ye L; Sui C; Kuang L; Lin D; Lu Y
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1196-202. PubMed ID: 26678239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD).
    Notarnicola M; Caruso MG; Tutino V; Bonfiglio C; Cozzolongo R; Giannuzzi V; De Nunzio V; De Leonardis G; Abbrescia DI; Franco I; Intini V; Mirizzi A; Osella AR
    Lipids Health Dis; 2017 Aug; 16(1):160. PubMed ID: 28830448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma Levels of Bile Acids Are Related to Cardiometabolic Risk Factors in Young Adults.
    Osuna-Prieto FJ; Rubio-Lopez J; Di X; Yang W; Kohler I; Rensen PCN; Ruiz JR; Martinez-Tellez B
    J Clin Endocrinol Metab; 2022 Feb; 107(3):715-723. PubMed ID: 34718617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet.
    Wang XH; Li CY; Muhammad I; Zhang XY
    Environ Toxicol Pharmacol; 2016 Jun; 44():140-50. PubMed ID: 27179602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
    Liu AN; Xu CF; Liu YR; Sun DQ; Jiang L; Tang LJ; Zhu PW; Chen SD; Liu WY; Wang XD; Targher G; Byrne CD; Wong VW; Fu J; Su MM; Loomba R; Zheng MH; Ni Y
    Aliment Pharmacol Ther; 2023 Apr; 57(8):872-885. PubMed ID: 36670060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advanced Liver Fibrosis Is Independently Associated with Palmitic Acid and Insulin Levels in Patients with Non-Alcoholic Fatty Liver Disease.
    Cansanção K; Silva Monteiro L; Carvalho Leite N; Dávalos A; Tavares do Carmo MDG; Arantes Ferreira Peres W
    Nutrients; 2018 Oct; 10(11):. PubMed ID: 30380656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease.
    Nasr P; Hilliges A; Thorelius L; Kechagias S; Ekstedt M
    Scand J Gastroenterol; 2016 Sep; 51(9):1126-32. PubMed ID: 27161854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Studies on pruritus in obstructive jaundice cases with special references to serum bile acid fractions].
    Mashima H
    Fukuoka Igaku Zasshi; 1991 Aug; 82(8):445-57. PubMed ID: 1937344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
    Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
    Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ratio of Conjugated Chenodeoxycholic to Muricholic Acids is Associated with Severity of Nonalcoholic Steatohepatitis.
    Chen J; Zheng M; Liu J; Luo Y; Yang W; Yang J; Liu J; Zhou J; Xu C; Zhao F; Su M; Zang S; Shi J;
    Obesity (Silver Spring); 2019 Dec; 27(12):2055-2066. PubMed ID: 31657148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.